Reduced volume formulation of glatiramer acetate and methods of administration

Details for Australian Patent Application No. 2010273234 (hide)

Owner Teva Pharmaceutical Industries Ltd.

Inventors Altman, Ayelet; El-Gad, Tomer; Saltkill, Doris; Tomlinson, Dalton; Greenhalgh, Paul; Robinson, David George

Agent FB Rice

Pub. Number AU-A-2010273234

PCT Pub. Number WO2011/008274

Priority 61/337,011 29.01.10 US; 61/271,009 15.07.09 US; 12/761,367 15.04.10 US; 61/271,340 20.07.09 US

Filing date 14 July 2010

Wipo publication date 20 January 2011

International Classifications

A61K 38/07 (2006.01) Medicinal preparations containing peptides - Tetrapeptides

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

23 February 2012 PCT application entered the National Phase

  PCT publication WO2011/008274 Priority application(s): WO2011/008274

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010273239-Method and apparatus for determining the relative positions of connectors

2010273224-Eyewear